Which has preferable valuation & earnings, SIBN or PDEX?

Pro-Dex has lower revenue, but higher earnings than SiBone. SiBone is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SiBone $200.93M 4.30 -$18.90M -$0.34 N/A Pro-Dex $66.59M 3.18 $8.98M $3.62 18.32

Is SIBN or PDEX more profitable?

Pro-Dex has a net margin of 16.08% compared to SiBone's net margin of -6.85%. Pro-Dex's return on equity of 22.78% beat SiBone's return on equity. Company Net Margins Return on Equity Return on Assets SiBone -6.85% -8.23% -6.07% Pro-Dex 16.08% 22.78% 14.30%

Does the media favor SIBN or PDEX?

In the previous week, SiBone had 3 more articles in the media than Pro-Dex. MarketBeat recorded 5 mentions for SiBone and 2 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.71 beat SiBone's score of 0.33 indicating that Pro-Dex is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SiBone 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Pro-Dex 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, PDEX or VREX?

Pro-Dex has higher earnings, but lower revenue than Varex Imaging. Pro-Dex is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pro-Dex $66.59M 3.18 $8.98M $3.62 18.32 Varex Imaging $844.60M 0.92 -$70.30M $0.52 35.56

Is PDEX or VREX more profitable?

Pro-Dex has a net margin of 16.08% compared to Varex Imaging's net margin of 2.55%. Pro-Dex's return on equity of 22.78% beat Varex Imaging's return on equity. Company Net Margins Return on Equity Return on Assets Pro-Dex 16.08% 22.78% 14.30% Varex Imaging 2.55% 9.19% 4.13%

Does the media favor PDEX or VREX?

In the previous week, Varex Imaging had 6 more articles in the media than Pro-Dex. MarketBeat recorded 8 mentions for Varex Imaging and 2 mentions for Pro-Dex. Varex Imaging's average media sentiment score of 0.97 beat Pro-Dex's score of 0.71 indicating that Varex Imaging is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pro-Dex 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Varex Imaging 5 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor SSII or PDEX?

In the previous week, SS Innovations International had 5 more articles in the media than Pro-Dex. MarketBeat recorded 7 mentions for SS Innovations International and 2 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.71 beat SS Innovations International's score of 0.19 indicating that Pro-Dex is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SS Innovations International 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Pro-Dex 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, PDEX or BBNX?

Pro-Dex has higher earnings, but lower revenue than Beta Bionics. Beta Bionics is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pro-Dex $66.59M 3.18 $8.98M $3.62 18.32 Beta Bionics $100.25M 8.74 -$73.20M -$1.65 N/A

Is PDEX or BBNX more profitable?

Pro-Dex has a net margin of 16.08% compared to Beta Bionics' net margin of -61.31%. Pro-Dex's return on equity of 22.78% beat Beta Bionics' return on equity. Company Net Margins Return on Equity Return on Assets Pro-Dex 16.08% 22.78% 14.30% Beta Bionics -61.31% -26.30% -23.25%

Does the media prefer PDEX or BBNX?

In the previous week, Pro-Dex and Pro-Dex both had 2 articles in the media. Pro-Dex's average media sentiment score of 0.71 beat Beta Bionics' score of 0.30 indicating that Pro-Dex is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pro-Dex 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Beta Bionics 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation and earnings, CBLL or PDEX?

Pro-Dex has lower revenue, but higher earnings than CeriBell. CeriBell is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CeriBell $89.06M 10.48 -$53.41M -$1.76 N/A Pro-Dex $66.59M 3.18 $8.98M $3.62 18.32

Is CBLL or PDEX more profitable?

Pro-Dex has a net margin of 16.08% compared to CeriBell's net margin of -64.73%. Pro-Dex's return on equity of 22.78% beat CeriBell's return on equity. Company Net Margins Return on Equity Return on Assets CeriBell -64.73% -44.85% -35.69% Pro-Dex 16.08% 22.78% 14.30%

Does the media refer more to CBLL or PDEX?

In the previous week, CeriBell had 14 more articles in the media than Pro-Dex. MarketBeat recorded 16 mentions for CeriBell and 2 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.71 beat CeriBell's score of 0.61 indicating that Pro-Dex is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CeriBell 8 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pro-Dex 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Pro-Dex (PDEX) Competitors

$66.31 -0.63 (-0.94%)

Closing price 04:00 PM Eastern

Extended Trading

$66.36 +0.05 (+0.07%)

As of 04:16 PM Eastern

Compare

PDEX vs. SIBN, VREX, SSII, BBNX, and CBLL

Should you buy Pro-Dex stock or one of its competitors? Pro-Dex's main competitors and comparable companies include SiBone (SIBN), Varex Imaging (VREX), SS Innovations International (SSII), Beta Bionics (BBNX), and CeriBell (CBLL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Pro-Dex compare to SiBone?

SiBone (NASDAQ:SIBN) and Pro-Dex (NASDAQ:PDEX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership.

98.1% of SiBone shares are held by institutional investors. Comparatively, 15.3% of Pro-Dex shares are held by institutional investors. 4.0% of SiBone shares are held by company insiders. Comparatively, 45.9% of Pro-Dex shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Pro-Dex has a net margin of 16.08% compared to SiBone's net margin of -6.85%. Pro-Dex's return on equity of 22.78% beat SiBone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SiBone	-6.85%	-8.23%	-6.07%
Pro-Dex	16.08%	22.78%	14.30%

SiBone has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.02, meaning that its stock price is 98% less volatile than the broader market.

In the previous week, SiBone had 3 more articles in the media than Pro-Dex. MarketBeat recorded 5 mentions for SiBone and 2 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.71 beat SiBone's score of 0.33 indicating that Pro-Dex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SiBone	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Pro-Dex	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Pro-Dex has lower revenue, but higher earnings than SiBone. SiBone is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SiBone	$200.93M	4.30	-$18.90M	-$0.34	N/A
Pro-Dex	$66.59M	3.18	$8.98M	$3.62	18.32

SiBone currently has a consensus price target of $24.17, indicating a potential upside of 24.06%. Pro-Dex has a consensus price target of $70.00, indicating a potential upside of 5.56%. Given SiBone's stronger consensus rating and higher possible upside, research analysts clearly believe SiBone is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SiBone	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

SiBone and Pro-Dex tied by winning 8 of the 16 factors compared between the two stocks.

How does Pro-Dex compare to Varex Imaging?

Pro-Dex (NASDAQ:PDEX) and Varex Imaging (NASDAQ:VREX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

Pro-Dex currently has a consensus price target of $70.00, suggesting a potential upside of 5.56%. Varex Imaging has a consensus price target of $16.88, suggesting a potential downside of 8.73%. Given Pro-Dex's stronger consensus rating and higher probable upside, analysts plainly believe Pro-Dex is more favorable than Varex Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Varex Imaging	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86

In the previous week, Varex Imaging had 6 more articles in the media than Pro-Dex. MarketBeat recorded 8 mentions for Varex Imaging and 2 mentions for Pro-Dex. Varex Imaging's average media sentiment score of 0.97 beat Pro-Dex's score of 0.71 indicating that Varex Imaging is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pro-Dex	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Varex Imaging	5 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Pro-Dex has a beta of 0.02, indicating that its share price is 98% less volatile than the broader market. Comparatively, Varex Imaging has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market.

Pro-Dex has higher earnings, but lower revenue than Varex Imaging. Pro-Dex is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$66.59M	3.18	$8.98M	$3.62	18.32
Varex Imaging	$844.60M	0.92	-$70.30M	$0.52	35.56

Pro-Dex has a net margin of 16.08% compared to Varex Imaging's net margin of 2.55%. Pro-Dex's return on equity of 22.78% beat Varex Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pro-Dex	16.08%	22.78%	14.30%
Varex Imaging	2.55%	9.19%	4.13%

15.3% of Pro-Dex shares are held by institutional investors. 45.9% of Pro-Dex shares are held by insiders. Comparatively, 4.6% of Varex Imaging shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Pro-Dex beats Varex Imaging on 11 of the 16 factors compared between the two stocks.

How does Pro-Dex compare to SS Innovations International?

SS Innovations International (NASDAQ:SSII) and Pro-Dex (NASDAQ:PDEX) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership.

Pro-Dex has a net margin of 16.08% compared to SS Innovations International's net margin of -23.73%. Pro-Dex's return on equity of 22.78% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-23.73%	-26.77%	-15.01%
Pro-Dex	16.08%	22.78%	14.30%

SS Innovations International presently has a consensus price target of $7.00, indicating a potential upside of 93.91%. Pro-Dex has a consensus price target of $70.00, indicating a potential upside of 5.56%. Given SS Innovations International's higher possible upside, equities research analysts clearly believe SS Innovations International is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

In the previous week, SS Innovations International had 5 more articles in the media than Pro-Dex. MarketBeat recorded 7 mentions for SS Innovations International and 2 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.71 beat SS Innovations International's score of 0.19 indicating that Pro-Dex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SS Innovations International	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Pro-Dex	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

SS Innovations International has a beta of -1.92, indicating that its share price is 292% less volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.02, indicating that its share price is 98% less volatile than the broader market.

15.3% of Pro-Dex shares are held by institutional investors. 45.9% of Pro-Dex shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Pro-Dex has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49M	17.02	-$12.13M	-$0.06	N/A
Pro-Dex	$66.59M	3.18	$8.98M	$3.62	18.32

Summary

Pro-Dex beats SS Innovations International on 12 of the 15 factors compared between the two stocks.

How does Pro-Dex compare to Beta Bionics?

Pro-Dex (NASDAQ:PDEX) and Beta Bionics (NASDAQ:BBNX) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends, institutional ownership and media sentiment.

15.3% of Pro-Dex shares are owned by institutional investors. 45.9% of Pro-Dex shares are owned by insiders. Comparatively, 5.3% of Beta Bionics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Pro-Dex presently has a consensus price target of $70.00, indicating a potential upside of 5.56%. Beta Bionics has a consensus price target of $20.10, indicating a potential upside of 3.18%. Given Pro-Dex's stronger consensus rating and higher possible upside, equities analysts plainly believe Pro-Dex is more favorable than Beta Bionics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Beta Bionics	1 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.55

Pro-Dex has a net margin of 16.08% compared to Beta Bionics' net margin of -61.31%. Pro-Dex's return on equity of 22.78% beat Beta Bionics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pro-Dex	16.08%	22.78%	14.30%
Beta Bionics	-61.31%	-26.30%	-23.25%

Pro-Dex has higher earnings, but lower revenue than Beta Bionics. Beta Bionics is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$66.59M	3.18	$8.98M	$3.62	18.32
Beta Bionics	$100.25M	8.74	-$73.20M	-$1.65	N/A

In the previous week, Pro-Dex and Pro-Dex both had 2 articles in the media. Pro-Dex's average media sentiment score of 0.71 beat Beta Bionics' score of 0.30 indicating that Pro-Dex is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pro-Dex	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Beta Bionics	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Pro-Dex has a beta of 0.02, meaning that its stock price is 98% less volatile than the broader market. Comparatively, Beta Bionics has a beta of 3.13, meaning that its stock price is 213% more volatile than the broader market.

Summary

Pro-Dex beats Beta Bionics on 10 of the 14 factors compared between the two stocks.

How does Pro-Dex compare to CeriBell?

CeriBell (NASDAQ:CBLL) and Pro-Dex (NASDAQ:PDEX) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, media sentiment, profitability, valuation and institutional ownership.

Pro-Dex has a net margin of 16.08% compared to CeriBell's net margin of -64.73%. Pro-Dex's return on equity of 22.78% beat CeriBell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CeriBell	-64.73%	-44.85%	-35.69%
Pro-Dex	16.08%	22.78%	14.30%

In the previous week, CeriBell had 14 more articles in the media than Pro-Dex. MarketBeat recorded 16 mentions for CeriBell and 2 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.71 beat CeriBell's score of 0.61 indicating that Pro-Dex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CeriBell	8 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pro-Dex	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

15.3% of Pro-Dex shares are held by institutional investors. 17.7% of CeriBell shares are held by company insiders. Comparatively, 45.9% of Pro-Dex shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

CeriBell presently has a consensus target price of $22.40, indicating a potential downside of 7.86%. Pro-Dex has a consensus target price of $70.00, indicating a potential upside of 5.56%. Given Pro-Dex's higher possible upside, analysts plainly believe Pro-Dex is more favorable than CeriBell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CeriBell	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

CeriBell has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.02, suggesting that its stock price is 98% less volatile than the broader market.

Pro-Dex has lower revenue, but higher earnings than CeriBell. CeriBell is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CeriBell	$89.06M	10.48	-$53.41M	-$1.76	N/A
Pro-Dex	$66.59M	3.18	$8.98M	$3.62	18.32

Summary

Pro-Dex beats CeriBell on 10 of the 17 factors compared between the two stocks.

Get Pro-Dex News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PDEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PDEX vs. The Competition

Export

Metric	Pro-Dex	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$213.72M	$5.96B	$7.37B	$12.86B
Dividend Yield	N/A	1.74%	2.53%	10.69%
P/E Ratio	18.32	21.39	209.18	20.84
Price / Sales	3.18	65.73	621.61	93.92
Price / Cash	21.35	33.51	78.13	53.57
Price / Book	5.90	5.90	13.07	6.15
Net Income	$8.98M	$148.28M	$3.46B	$347.39M
7 Day Performance	-2.34%	0.55%	1.43%	-0.64%
1 Month Performance	21.31%	5.75%	4.58%	2.12%
1 Year Performance	48.21%	9.08%	27.60%	20.16%

Pro-Dex Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PDEX Pro-Dex	1.7638 of 5 stars	$66.31 -0.9%	$70.00 +5.6%	+52.4%	$213.72M	$66.59M	18.32	140	News Coverage
SIBN SiBone	2.9037 of 5 stars	$18.80 -0.2%	$24.17 +28.5%	+28.5%	$835.54M	$213.60M	N/A	350	Positive News
VREX Varex Imaging	2.8503 of 5 stars	$18.58 +0.7%	$16.88 -9.2%	+63.8%	$777.17M	$844.60M	35.73	2,400	Analyst Downgrade High Trading Volume
SSII SS Innovations International	2.2065 of 5 stars	$3.61 -3.7%	$7.00 +93.9%	-45.5%	$750.49M	$42.49M	N/A	4	Earnings Report Short Interest Decrease
BBNX Beta Bionics	0.8862 of 5 stars	$17.62 +7.4%	$20.10 +14.1%	+26.0%	$737.83M	$100.25M	N/A	294	Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PDEX) was last updated on 8/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Pro-Dex (PDEX) Competitors

PDEX vs. SIBN, VREX, SSII, BBNX, and CBLL

How does Pro-Dex compare to SiBone?

Summary

How does Pro-Dex compare to Varex Imaging?

Summary

How does Pro-Dex compare to SS Innovations International?

Summary

How does Pro-Dex compare to Beta Bionics?

Summary

How does Pro-Dex compare to CeriBell?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PDEX vs. The Competition

Pro-Dex Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Pro-Dex (PDEX) Competitors

PDEX vs. SIBN, VREX, SSII, BBNX, and CBLL

How does Pro-Dex compare to SiBone?

Do insiders & institutionals have more ownership in SIBN or PDEX?

Is SIBN or PDEX more profitable?

Which has more volatility & risk, SIBN or PDEX?

Does the media favor SIBN or PDEX?

Which has preferable valuation & earnings, SIBN or PDEX?

Do analysts recommend SIBN or PDEX?

Summary

How does Pro-Dex compare to Varex Imaging?

Do analysts rate PDEX or VREX?

Does the media favor PDEX or VREX?

Which has more volatility & risk, PDEX or VREX?

Which has preferable valuation and earnings, PDEX or VREX?

Is PDEX or VREX more profitable?

Do insiders and institutionals hold more shares of PDEX or VREX?

Summary

How does Pro-Dex compare to SS Innovations International?

Is SSII or PDEX more profitable?

Do analysts rate SSII or PDEX?

Does the media favor SSII or PDEX?

Which has more risk & volatility, SSII or PDEX?

Do insiders and institutionals have more ownership in SSII or PDEX?

Which has higher valuation and earnings, SSII or PDEX?

Summary

How does Pro-Dex compare to Beta Bionics?

Do institutionals and insiders have more ownership in PDEX or BBNX?

Do analysts recommend PDEX or BBNX?

Is PDEX or BBNX more profitable?

Which has higher earnings and valuation, PDEX or BBNX?

Does the media prefer PDEX or BBNX?

Which has more volatility and risk, PDEX or BBNX?

Summary

How does Pro-Dex compare to CeriBell?

Is CBLL or PDEX more profitable?

Does the media refer more to CBLL or PDEX?

Do institutionals & insiders have more ownership in CBLL or PDEX?

Do analysts recommend CBLL or PDEX?

Which has more volatility & risk, CBLL or PDEX?

Which has higher valuation and earnings, CBLL or PDEX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PDEX vs. The Competition

Pro-Dex Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools